People with sickle cell disease are at greater risk for severe illness from COVID-19, but what about the nearly 3 million Americans who have the sickle cell trait and don’t even know it? A new study underway at Grady Memorial Hospital in Atlanta looks to determine whether these individuals are also at risk, reports STAT.… Read More: Are Those With Sickle Cell Trait More at Risk of… »
The vaccine — developed through a collaboration between BIDMC and Johnson & Johnson (J&J) — uses a common cold virus, called adenovirus serotype 26 (Ad26), to deliver the SARS-CoV-2 spike protein into host cells, where it stimulates the body to raise immune responses against the coronavirus. Barouch’s group and J&J developed a series of vaccine… Read More: Vaccine protection against COVID-19 related issues »
By Michael Le Page , Clare Wilson , Jessica Hamzelou , Adam Vaughan , Conrad Quilty-Harper and Layal Liverpool A medical worker takes a swab to test for the coronavirus at a drive-in testing facilityADRIAN DENNIS/AFP via Getty Images Latest coronavirus news as of 5 pm on 3 September New funding announced for trials of… Read More: Covid-19 news: UK funding for trials of rapid new coronavirus… »
It’s the conversations with a local barista, a bus driver, a casual work acquaintance, or a person in line at the store that make up what the experts call “weak ties”: individuals we don’t know well, if at all, but who nevertheless contribute to our happiness and sense of belonging. These encounters have largely gone… Read More: COVID-19 is evaporating casual connections and why that’s bad »